Stay updated on Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.

Latest updates to the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page
- Check2 days agoChange DetectedAdded the term 'Severe myoclonic epilepsy in infancy' as a keyword/MeSH term and removed 'Dravet syndrome'.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the site.SummaryDifference0.0%

- Check17 days agoChange DetectedAdded a Publications section with a 2026 NEJM article citation (Zorevunersen in Dravet Syndrome) and PubMed attribution, and noted a revision to version v3.4.3.SummaryDifference0.3%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedRevision: v3.4.2 was added; older notices about funding lapse and NIH operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check52 days agoChange DetectedThe page now displays a government funding/status notice at the top and the revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check59 days agoChange DetectedUI labels and version metadata were updated (Show glossary added, capitalization/wording tweaks for QC labels, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.